Recall of Various Microgenics Application Sheets. An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Thermo Fisher Scientific Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00692-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2017-06-14
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    During an internal assessment, thermo fisher scientific found that application sheets provided by the manufacturer microgenics for expanded use of some assays are inadequate. specifically, the appropriate validation data for the expanded use of these assays, as indicated in the instructions for use (ifu) when not used on manufacturer approved analysers, is inadequate. in addition, microgenics did not clearly state in these application sheets that the parameters provided are only to be used as starting points and that each assay setting needs to be validated individually by the user.Thus the information given on the specific application sheets for use with non-microgenics approved analysers may be ineffective. it is possible that assays not validated for use with other instrument platforms could potentially lead to erroneously low or high test results.
  • Action
    Thermo Fisher Scientific is requesting users to 1) immediately discontinue use of the affected application sheets used on their specific instrument platform, 2) review their internal assay validations to determine if their current instrument settings using these assays require additional action within their clinical laboratory settings (consult a qualified healthcare professional, as appropriate) and 3) contact Customer Service to check if additional action is required.

Device

  • Model / Serial
    Various Microgenics Application Sheets. An in vitro diagnostic medical device (IVD)Multiple Assays / Instrument PlatformsARTG Numbers: 192621 and 235822
  • Manufacturer

Manufacturer